Response to the comment on “Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients”

por Blyuss, Oleg, Crnogorac-Jurcevic, Tatjana
Publicado 2020

Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer—A Comprehensive Review

por Brezgyte, Greta, Shah, Vinay, Jach, Daria, Crnogorac-Jurcevic, Tatjana
Publicado 2021

Nutraceuticals as Supportive Therapeutic Agents in Diabetes and Pancreatic Ductal Adenocarcinoma: A Systematic Review

por Mikolaskova, Iveta, Crnogorac-Jurcevic, Tatjana, Smolkova, Bozena, Hunakova, Luba
Publicado 2023

Demographic, clinical, and pathological features of early onset pancreatic cancer patients

por Ntala, Chara, Debernardi, Silvana, Feakins, Roger M., Crnogorac-Jurcevic, Tatjana
Publicado 2018

Non-Invasive Biomarkers for Early Lung Cancer Detection

por Saman, Harman, Raza, Afsheen, Patil, Kalyani, Uddin, Shahab, Crnogorac-Jurcevic, Tatjana
Publicado 2022

The Pancreatic Expression database: 2011 update

por Cutts, Rosalind J., Gadaleta, Emanuela, Hahn, Stephan A., Crnogorac-Jurcevic, Tatjana, Lemoine, Nicholas R., Chelala, Claude
Publicado 2011

A global insight into a cancer transcriptional space using pancreatic data: importance, findings and flaws

por Gadaleta, Emanuela, Cutts, Rosalind J., Kelly, Gavin P., Crnogorac-Jurcevic, Tatjana, Kocher, Hemant M., Lemoine, Nicholas R., Chelala, Claude
Publicado 2011

Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients

por Blyuss, Oleg, Zaikin, Alexey, Cherepanova, Valeriia, Munblit, Daniel, Kiseleva, Elena M., Prytomanova, Olga M., Duffy, Stephen W., Crnogorac-Jurcevic, Tatjana
Publicado 2019

Pancreatic Expression database: a generic model for the organization, integration and mining of complex cancer datasets

por Chelala, Claude, Hahn, Stephan A, Whiteman, Hannah J, Barry, Sayka, Hariharan, Deepak, Radon, Tomasz P, Lemoine, Nicholas R, Crnogorac-Jurcevic, Tatjana
Publicado 2007

The Pancreatic Expression Database: 2018 update

por Marzec, Jacek, Dayem Ullah, Abu Z, Pirrò, Stefano, Gadaleta, Emanuela, Crnogorac-Jurcevic, Tatjana, Lemoine, Nicholas R, Kocher, Hemant M, Chelala, Claude
Publicado 2018

Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis

por Debernardi, Silvana, Blyuss, Oleg, Rycyk, Daria, Srivastava, Kirtiman, Jeon, Christie Y., Cai, Hui, Cai, Qiuyin, Shu, Xiao‐Ou, Crnogorac‐Jurcevic, Tatjana
Publicado 2022

The pancreatic expression database: recent extensions and updates

por Dayem Ullah, Abu Z., Cutts, Rosalind J., Ghetia, Millika, Gadaleta, Emanuela, Hahn, Stephan A., Crnogorac-Jurcevic, Tatjana, Lemoine, Nicholas R., Chelala, Claude
Publicado 2014

Molecular Analysis of Precursor Lesions in Familial Pancreatic Cancer

por Crnogorac-Jurcevic, Tatjana, Chelala, Claude, Barry, Sayka, Harada, Tomohiko, Bhakta, Vipul, Lattimore, Sam, Jurcevic, Stipo, Bronner, Mary, Lemoine, Nicholas R., Brentnall, Teresa A.
Publicado 2013

AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting

por Liu, Alvin Y., Kanan, Adelle D., Radon, Tomasz P., Shah, Siama, Weeks, Mark E., Foster, Julie M., Sosabowski, Jane K., Dumartin, Laurent, Crnogorac-Jurcevic, Tatjana
Publicado 2019

Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling

por Alrawashdeh, Wasfi, Jones, Richard, Dumartin, Laurent, Radon, Tomasz P., Cutillas, Pedro R., Feakins, Roger M., Dmitrovic, Branko, Demir, Ihsan Ekin, Ceyhan, Guralp O., Crnogorac‐Jurcevic, Tatjana
Publicado 2019

Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies

por Schröder, Christoph, Jacob, Anette, Tonack, Sarah, Radon, Tomasz P., Sill, Martin, Zucknick, Manuela, Rüffer, Sven, Costello, Eithne, Neoptolemos, John P., Crnogorac-Jurcevic, Tatjana, Bauer, Andrea, Fellenberg, Kurt, Hoheisel, Jörg D.
Publicado 2010

Splice variants as novel targets in pancreatic ductal adenocarcinoma

por Wang, Jun, Dumartin, Laurent, Mafficini, Andrea, Ulug, Pinar, Sangaralingam, Ajanthah, Alamiry, Namaa Audi, Radon, Tomasz P., Salvia, Roberto, Lawlor, Rita T., Lemoine, Nicholas R., Scarpa, Aldo, Chelala, Claude, Crnogorac-Jurcevic, Tatjana
Publicado 2017

Palladin Mutation Causes Familial Pancreatic Cancer and Suggests a New Cancer Mechanism

por Pogue-Geile, Kay L, Chen, Ru, Bronner, Mary P, Crnogorac-Jurcevic, Tatjana, Moyes, Kara White, Dowen, Sally, Otey, Carol A, Crispin, David A, George, Ryan D, Whitcomb, David C, Brentnall, Teresa A
Publicado 2006

A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma

por Haider, Syed, Wang, Jun, Nagano, Ai, Desai, Ami, Arumugam, Prabhu, Dumartin, Laurent, Fitzgibbon, Jude, Hagemann, Thorsten, Marshall, John F, Kocher, Hemant M, Crnogorac-Jurcevic, Tatjana, Scarpa, Aldo, Lemoine, Nicholas R, Chelala, Claude
Publicado 2014

Discovery of novel small molecule inhibitors of S100P with in vitro anti-metastatic effects on pancreatic cancer cells

por Camara, Ramatoulie, Ogbeni, Deborah, Gerstmann, Lisa, Ostovar, Mehrnoosh, Hurer, Ellie, Scott, Mark, Mahmoud, Nasir G., Radon, Tomasz, Crnogorac-Jurcevic, Tatjana, Patel, Pryank, Mackenzie, Louise S., Chau, David Y.S., Kirton, Stewart B., Rossiter, Sharon
Publicado 2020